Both in Pharmaceuticals
Ensysce Biosciences vs FibroBiologics
Over the past year ENSC returned −80.4% and FBLG returned −88.8%; their daily moves had a correlation of 0.03.
ENSC −80.4% FBLG −88.8%Growth of $1, one year, split-adjusted
| Metric | ENSC | FBLG |
|---|---|---|
| Price | $0.4986 | $0.9199 |
| Market cap | $9.7M | $6.5M |
| Today | −0.85% | −2.56% |
| 1 month | +18.4% | −32.4% |
| 6 months | +10.4% | −39.5% |
| Year to date | −45.8% | −79.5% |
| 1 year | −79.1% | −88.5% |
| Revenue growth (YoY) | −15.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −220.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | — |
| Net cash | $479.9K | $3.5M |
| Dividend yield | — | — |
| Volatility (60d) | 137.5% | 105.6% |
| Short % of float | 7.5% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).